Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children With Partial Onset Seizures
Read time: 1 mins
Last updated:14th Oct 2013
Study to evaluate the long-term safety and tolerability of Lacosamide (LCM) administered in addition to 1 to ?3 other Anti-Epileptic Drugs in subjects with epilepsy ?1 month to ?18 years who currently have uncontrolled partial onset seizures.
|Study start date||2013-10-14|